| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |